Cannabis misuse clinical trials
43 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
- Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
- Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum
- CARS: Cannabis and Alcohol Reduction Study
- Young Adult Tobacco/Nicotine and Cannabis Co-use
- Perceptual Influences From Smoking Cannabis: an Experimental Study
- Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
- Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
- MiREA-AC for Reducing Problematic Alcohol and Marijuana Use in College Students
- Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment
- Study of Oral Fluid Testing Approach
- THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
- Stress and Resilience
- Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use
- Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
- Neural and Psychiatric Consequences of Cannabis Use in Adolescents
- SV2A in Older Adults
- Cannabis' Impact on Alcohol Consumption
- Repeated CBD Administration and Cannabis Outcomes
- Effect of Cannabis on Cigarette Use Behavior
- Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
- The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
- Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults
- Effect of Cannabis on E-Cigarette Use Behavior
- Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation
- Substance Use in Assault-Injured Young Adults
- Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
- Brief Family-Based Cannabis Use Intervention for Youth With Early Juvenile Justice Involvement
- Developing and Strengthening Cannabis Warnings: Warning Message Testing
- Development of an Alcohol, Cannabis, and Sexual Assault Risk Reduction Program for High Risk College Women
- Clinician Practice Companion to Address Youth Substance Use
- Cannabis Effects on Opioid Self-Administration
- Cannabis and Opioid Use Disorder, Study 2
- Research Investigating Drug Effects-2 (RiDE-2)
- Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
- Behavioral Pharmacology of THC and Beta-Myrcene
- Acute Effects of Cannabis on Cognition and Affect
- Evaluation of Oral THC and CBD in Men and Women
- Changes in Cognition and Psychiatric Disorder Symptoms During Cannabis Abstinence Using a Novel Discordant Twin Design
- Perceptions of Proposed Warnings for Cannabis Edibles Packaging
- Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
- Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
- Cannabis Effects as a Function of Sex
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cannabis misuse” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.